Pills, Pot and Powdery Substance – Practical Considerations for MFMs in Addressing Perinatal Substance Use
Jan. 27, 2021 11am - 3pm
Course Directors:
Marcela Smid, MD
Courtney Townsel, MD
Course Description:
This case-based session is designed to provide MFMs with practical tools to assess and manage pregnancies complicated by drug use. We will review evidence-based approaches for screening, diagnosing and optimizing care for women with substance use disorders. The session will review impact of opioid and methamphetamine epidemics on pregnant and parenting women. There will be emphasis on practical steps for peripartum pain management and drug testing, including utility and pitfalls of urine drug testing and biological testing of the newborn. Given the increasing legalization of marijuana, a portion of the session will be dedicated to reviewing the data on marijuana use in pregnancy and breastfeeding with emphasis on practical tools for counseling and treatment during pregnancy.
Learning Objectives:
Course Schedule (All times Eastern Standard Time):
Please click here to view the course schedule and additional details. >>
CME Credits: 3.5
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Learning Collaborative (GLC) and SMFM. GLC is accredited by the ACCME to provide continuing medical education for physicians.
Global Learning Collaborative designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This case-based session is designed to provide MFMs with practical tools to assess and manage pregnancies complicated by drug use. We will review evidence-based approaches for screening, diagnosing and optimizing care for women with substance use disorders. The session will review impact of opioid and methamphetamine epidemics on pregnant and parenting women. There will be emphasis on practical steps for peripartum pain management and drug testing, including utility and pitfalls of urine drug testing and biological testing of the newborn. Given the increasing legalization of marijuana, a portion of the session will be dedicated to reviewing the data on marijuana use in pregnancy and breastfeeding with emphasis on practical tools for counseling and treatment during pregnancy.
Learning Objectives:
- Describe the management of pregnant and postpartum women with substance use disorders (stimulant and opioid use disorder) including evidence-based counseling regarding pharmacotherapy and behavioral treatments, post-delivery pain management consideration and neonatal abstinence/neonatal opioid withdrawal syndrome.
- Review the current data regarding marijuana use in pregnancy and counseling recommendations including use in pregnancy and breastfeeding.
- Describe utilization and limitations of drug testing during pregnancy and newborn testing including state specific laws and provider obligations.
Course Schedule (All times Eastern Standard Time):
Please click here to view the course schedule and additional details. >>
CME Credits: 3.5
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Global Learning Collaborative (GLC) and SMFM. GLC is accredited by the ACCME to provide continuing medical education for physicians.
Global Learning Collaborative designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Price: $400.00